MedTrace Logo

Duke Scleroderma Clinic Patient Registry

NCT02851875 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2021-01-29

No results posted yet for this study

Summary

The purpose of the Duke Scleroderma Registry (DSScR) is to obtain information about scleroderma. This information could be used in future research to increase the understanding of disease mechanisms, treatments, and outcomes. This research may also help develop new therapies, novel measures of disease assessment or identify previously unknown manifestations of the diseases. A prospectively followed cohort is an integral component of future translational and clinical research programs. A registry for scleroderma would allow for information to be gleaned about patients in "real-world situations" in an effort to improve the reality, generalizability and applicability of information gathered.

Conditions

Interventions

OTHER

Registry

Sponsors & Collaborators

Principal Investigators

  • Ankoor Shah, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-05-07
Completion
2018-05-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02851875 on ClinicalTrials.gov